Dear Friends,
THESE PAST FEW MONTHS I HAVE BEEN FOCUSING MUCH OF
MY ATTENTION ON ENCOURAGING THE SCHOOL OF MEDICINE'S RESEARCHERS
TO CROSS DISCIPLINARY BOUNDARIES. I believe that interdisciplinary
collaborations are key to spurring advances in medical education,
research and care. As I meet with faculty and administrators throughout
Stanford University to set up collaborative research programs and
build bridges, one thought continually returns to my mind: We are
fortunate that Stanford University School of Medicine is located
right here -- on the Stanford University campus.
As many of you know, the Palo Alto campus was not
always the School of Medicine's location. The school was in San
Francisco until just over 40 years ago when Stanford's leadership
decided to move it to Palo Alto. If these individuals had not decided
to move the School of Medicine in 1959, we most certainly would
not see today's wealth of promising collaborations between researchers
at the School of Medicine and those in Stanford's non-medical departments
and schools. The ease of carrying out such interdisciplinary projects
is one of Stanford's prized assets today.
School of Medicine leaders, along with our counterparts
at the University, are generating ideas for programs to stimulate
such cross-pollination. Some of these programs, such as Bio-X, I
have described to you in previous letters. Bio-X, still in its planning
stages, will coordinate faculty and students from medicine, biology,
chemistry, engineering and physics to develop new approaches to
explore the fundamental structures and systems of living organisms
and to translate these discoveries into new approaches to understand,
treat and cure disease. The program's hub will be a new 225,000-square-foot
building located close to the medical campus, the School of Engineering
and the School of Humanities and Sciences.
But there are many more programs in progress. One
I would like to tell you about is the Stanford Center for Cardiovascular
Research -- our effort to translate cardiovascular research findings
into clinical practices for diagnosis and treatment. We are creating
a program that brings together researchers from disciplines as diverse
as communications, economics, engineering and molecular biology
to take advantage of their great potential to expand the development
of diagnostics, therapies and preventive strategies for cardiovascular
disease. The center will focus on six areas: biomedical engineering,
development of the cardiovascular system, disease prevention, genetics,
outcomes research and replacement biology -- a theme that extends
from the one extreme of manipulating stem cells to the other extreme
of creating artificial organ systems.
All six of the center's programs will involve interdepartmental
efforts within the School of Medicine, and many will involve collaborations
with departments outside of the school. Two in particular -- biomedical
engineering and replacement biology -- almost certainly would be
impossible without our location here on campus, just a few minutes'
walk from the School of Engineering.
The possibility for research and clinical advancement
that inter-school collaborations hold is a big part of what makes
Stanford unique. Our proximity to economists, engineers, statisticians
and other non-medical specialists provides us easy access to valuable
tools and perspectives many medical researchers lack. With explicitly
collaborative programs such as the cardiovascular research program
in place, I am optimistic that we will continue to make the most
of this opportunity.
Cordially yours,
EUGENE A. BAUER, MD
Vice President, Stanford University
Medical Center
Dean, Stanford University School of
Medicine
|